Dublin, Feb. 05, 2024 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ResearchAndMarkets.com's offering.
The prolific growth in the cancer immunotherapy sector, fuelled by technological advances and a high prevalence of cancer-related cases, is set to significantly enhance the global market landscape. The market, which was valued at US$ 96.40 billion in 2023, is estimated to achieve a remarkable CAGR of 10.02% between the years 2023 and 2030, with projections placing its value at approximately US$ 188.11 billion by the end of the decade. These insights emerge from this comprehensive industry report that presents a nuanced analysis of market dynamics, shares, and growth trends impacting the cancer immunotherapy domain.
Cancer immunotherapy revolutionizes cancer care by harnessing the body's immune system, offering long-term protection and minimal side effects across diverse cancer types. The shift from traditional treatment modalities, such as chemotherapy, to cancer immunotherapy reflects the global healthcare sector's commitment to improving patient outcomes and longevity.
This research thoroughly examines a broad spectrum of market segments, focusing on products like monoclonal antibodies, immunomodulators, and cancer vaccines. Monoclonal antibodies, lauded for their precise immune system modulation, have emerged as market front runners due to their widespread application in cancer treatments and robust effectiveness.
The study segments the market by application and highlights that lung cancer remains the dominant category, largely due to soaring global incidence rates and a surge in awareness regarding the importance of early detection and treatment.
When analyzing the market by end-users, the report underscores that hospitals are at the forefront of adopting immunotherapy treatments. Their comprehensive medical capabilities and infrastructure place them at the core of executing these advanced therapeutic strategies. Moreover, the rising occurrence of cancer cases globally thereby turning hospitals into primary centers for these cutting-edge treatments.
From a geographical lens, the report delves into numerous regions, with a notable focus on China's fast-growing market. China's vast population, high rates of cancer, and strong government support make it a significant contributor to the growth of the cancer immunotherapy sector in the Asia Pacific region. Partnerships between local and international players are fostering advancements in research and development, contributing to a competitive and innovative market environment.
The study provides insights into leading companies that are shaping the trajectory of the cancer immunotherapy market. Through analysis of recent developments and financial insights, it presents a comprehensive view of strategies employed by organizations to maintain and grow their market presence.
This research sheds light on a highly dynamic market poised for profound growth, driven by a synergistic combination of scientific advances, market demand, and the urgent necessity to address the global cancer burden. As the industry reaches new heights, this report serves as an essential tool for understanding the intricate workings of the cancer immunotherapy market and the forces propelling its expansion.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 190 |
| Forecast Period | 2023-2030 |
| Estimated Market Value (USD) in 2023 | $96.4 Billion |
| Forecasted Market Value (USD) by 2030 | $188.11 Billion |
| Compound Annual Growth Rate | 10.2% |
| Regions Covered | Global |
Companies Mentioned
- Seattle Genetics Inc.
- Eli Lilly & Company
- Johnson & Johnson
- Novartis AG
- Pfizer Inc.
- Bristol-Myers Squibb Company
- Bayer AG
- AstraZeneca
- Amgen Inc.
For more information about this report visit https://www.researchandmarkets.com/r/mtbob3
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
